Representatives Eliot L. Engel (D-NY-16), Fred Upton (R-MI-06), Pete King (R-NY-02) and TJ Cox (D-CA-21), all members of the House Asthma and Allergy Caucus, have introduced legislation to honor Elijah E. Cummings’ long-time advocacy for those living with asthma. The Elijah E. Cummings Family Asthma Act would expand federal, state, and local efforts to improve care for individuals with asthma.
Are metered dose inhalers (MDIs) contributing to climate change? British researchers estimated the impact of gases used in MDIs on air pollution. They suggest if people switched to dry powder inhalers (DPIs), it could reduce the impact on our planet. What does this mean for people with asthma?
Welcome to our first monthly advocacy update. My name is Jenna Riemenschneider, Director of Advocacy at the Asthma and Allergy Foundation of America (AAFA). I'm pictured above with Mark Vieth, Senior Vice President at Cavarocchi Ruscio Dennis Associates, at a meeting with Airlines for America. Through this monthly blog series, I will update you on our advocacy efforts. We have already had a busy fall. This first post will include our September and October activity.
As part of National Eczema Awareness Month, we want to build better public awareness about eczema. One way we can do that is to share your eczema stories.
On Oct. 17, 2019, Representative Elijah Cummings (D-MD) passed away. Representative Cummings was an influential voice in support of people with asthma and allergies.
State policies can help protect students with asthma and allergies. As part of our 2019 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR), we look at ways the School-Based Allergies and Asthma Management Program Act can benefit both students and states.
As part of our 2019 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR), we look at the impact poor indoor air quality in schools can have on students with asthma and allergies.
Vaping is causing serious lung disease in many teens. Yet, youth vaping continues to rise at an alarming rate. State policies can help curb youth vaping. As part of our 2019 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR), we look at the rise of vaping among our youth and what states can do to reduce rates.
Schools provide valuable education to students. But the very resource that is supposed to benefit our children can actually be a cause of asthma symptoms and allergic reactions. Some states have policies in place that protect children with asthma and allergies. These 15 states made our 2019 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR). See how your state ranks.
Many children are affected by asthma and allergy triggers at school, such as mold, dust mites and strong cleaning chemicals. But Mark Jones can tell you firsthand that teachers can be affected too.
The Asthma and Allergy Foundation of America (AAFA) met with the Office of the General Counsel of the U.S. Department of Transportation (DOT). We spoke with members of their Office of Aviation Enforcement and Proceedings and Consumer Protection Division on behalf of people with asthma and allergies. We shared how critical it is that people with asthma and allergies who have to be on planes with emotional support animals have equal rights.
AAFA has joined with four other nonprofit organizations that serve people with eczema to launch “More Than Skin Deep.” This project will inform and shape the development of treatments for eczema. A main part the project is a patient-focused drug development (PFDD) meeting on Sept. 23, 2019, in Washington, D.C.
The Internal Revenue Service (IRS) recently made a change that could affect preventive asthma care. This change means some of your asthma medicines may become more affordable if you have a high deductible health plan (HDHP).
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
AAFA applauds the warning the U.S. Department of Transportation (USDOT) issued to American Airlines in response to American Airline’s denial of the right to pre-board a family of a child with food allergies. However, AAFA calls on the USDOT and Congress to take even stronger actions to protect the rights of airline passengers with allergies and all disabilities.